When considering the primary targets and specific treatment area/format, can anyone here say with confidence that they've invested time in researching biotech opportunities in the EU/US and believe that what IMU possess is by far and away more superior than that of any other listed company with pre-clinical & advanced P1/P2 assets? Are we a global standout (compared to our peers), or are there plenty of 'competitor's' with as avid following that expect that their company will be the one to truly break ground first?
In no way am I trying to be a downer (held strong since 2019) - Just wondering if we've all truly chosen the crowd favourite, or if we've hitched ourselves to the hottest thing going in our (very, very) small domestic market.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-7162
-
- There are more pages in this discussion • 7,946 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 1854997 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 382882 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 1694499 | 0.052 |
37 | 4870470 | 0.051 |
51 | 4160179 | 0.050 |
17 | 2263068 | 0.049 |
19 | 954663 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 282882 | 3 |
0.054 | 2751851 | 4 |
0.055 | 1611272 | 15 |
0.056 | 2792035 | 11 |
0.057 | 700330 | 7 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |